NCT02793583 · Interventional trial
Study to Assess the Efficacy and Safety of Ublituximab + Umbralisib With or Without Bendamustine and Umbralisib Alone in Patients With Previously Treated Non-Hodgkins Lymphoma
Overall registry status Terminated
Phase 2 · Phase 3
Conditions Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Small Lymphocytic Lymphoma
Delaware Valley sites
- TG Therapeutics Investigational Trial Site · Mount Holly, NJ · Burlington County
- TG Therapeutics Investigational Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory